AARDEX is collaborating with Pfizer to implement MEMS® in the FORWARD National Databank for Rheumatic Diseases to derive real world evidence adherence data.
Read more on recent MTX adherence publication
AARDEX’s scientific lead Bernard Vrijens is a co-author of the new publication in the Osteoporosis International journal about determinants, consequences and potential solutions to poor adherence to anti-osteoporosis treatment.
Discover why the Pharmaceutical world trusts us to resolve patient non-compliance.
Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019 annual meeting of the ERS, Madrid, Spain, September 30, 2019.
Discover our CEO’s last publication in the British Journal of Clinical Pharmacology
AARDEX Group, the leader in medication adherence monitoring and management
Bernard Vrijens, CEO of AARDEX Group, is invited as a guest speaker at the 2019
AARDEX still confirms its leading position in the B2B medication adherence market